MediConnect (MEDI) ICO 评级和细节

ICO

2019. 2. 20.

2019. 4. 3.

100% 완료된

기금 모금 - 데이터 없음

past

Private sale

2019. 1. 16.

2019. 2. 6.

100% 완료된

기금 모금 - 데이터 없음

10 000 000.00 USD

past

토큰 세부 정보

증권 시세 표시기

MEDI

허용 된 통화

BTC, STRAT

기업 세부 정보

등록 된 국가

United Kingdom

추가 세부 사항

KYC

예

카테고리

플랫폼

약 MediConnect

환자, 처방 자, 약국 및 의약품 제조업체를위한 안전망.

MediConnect는 약국 부문의 모든 규제 기관이 온라인 처방 의약품의 과다 처방 문제를 인식하고 우려함으로써 MediConnect가이 문제를 즉시 해결할 수있는 솔루션을 제공 할 수 있습니다.

Prescribers & amp; MediConnect를 사용하는 약국은 당사의 블록 체인 솔루션을 사용함으로써 잠재적 인 중독자에게 처방 의약품을 오용하고 과도하게 처방한다는 확신을 갖게됩니다. 누가 보통 약물 치료를 위해 온라인 쇼핑을 할 것인가? 제거 될 것입니다.

환자는 처방 된 의약품이 정품인지, 자신의 의무 관리를 향상시키는 데 도움이되는 금 표준 솔루션을 사용하는 허가 된 제조업체, 처방 자 및 약국으로부터 보증을받습니다.

% name % 로드맵

Q1 2018

Conceived Idea and scoped out requirements of a Prescription Drug Addiction Database.

Q2 2018

Agreed blockchain platform partnership with Stratis.

Q3 2018

Presented idea of a regional trial of East Midlands Pharmacies with newly formed Nottingham Addiction Safeguarding Committee.

Q4 2018

Jason Timms appointed chair of the official Prescription Drug Addiction (PDA) Working Group with the BBFA to tackle over prescribing, drug recalls, counterfeit drug reduction.
Agreed contract start date with ASC Nottingham for Q2 2019 and the onboarding of 2 Pharmacies to MediConnect.
Attended all Chairperson Meeting of the BBFA working groups to look at collaborative opportunities of the PDA on legal, identity, master data, assurance and Cybersecurity working groups.

Q1 2019

ICO Public Sale.
PDA Working Group meeting – Invites to attend to CQC, MHRA, GPhC, LPC, Pharma wholesale and retail industry.

Q2 2019

Commence contract with the ASC to support the Nottingham Trial and UK roll out programme.
Tower Pharmacy & UK Meds will be first 2 Pharmacies on the ASC blockchain solution from MediConnect.
6 other Pharmacies will be integrated, including 1 NHS Hospital outpatient dispensing pharmacy.

Q3 2019

Collaboration with Local Pharmacy Groups and membership committee to inform on pilot and expand reach to 20 further pharmacies in Nottingham, Derby & Leicester.
Partnership with Pharmacy Wholesaler – implementation of drug recall and counterfeit medication system.

Q4 2019

Publish trial research and outcomes – present at PDA meeting to CQC, MHRA. GPhC, LPC and Industry.

Q1 2020

The MediConnect platform will demonstrate an improved duty of care and detection that will see a reduction in pharmacy insurance for Pharmacies.

Q2 2020

Will see the recruitment of 500 UK Pharmacies join MediConnect through the expansion of the ASC membership in the UK.

Q3 2020

Aim for MediConnect to be the Industry standard solution for traceability of drugs for recall and counterfeit medication detection.

Q4 2020

The ASC achieves it’s goal of UK Pharmacies required to be members of the ASC and the MediConnect platform is used by all UK pharmacies